Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES PHARMA SCIENCE PANACEA BIOTECH STRIDES PHARMA SCIENCE/
PANACEA BIOTECH
 
P/E (TTM) x -1,455.3 -60.9 - View Chart
P/BV x 3.3 0.9 372.4% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 STRIDES PHARMA SCIENCE   PANACEA BIOTECH
EQUITY SHARE DATA
    STRIDES PHARMA SCIENCE
Mar-23
PANACEA BIOTECH
Mar-23
STRIDES PHARMA SCIENCE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs392191 205.0%   
Low Rs263107 245.9%   
Sales per share (Unadj.) Rs408.575.1 543.9%  
Earnings per share (Unadj.) Rs-25.6-5.5 464.1%  
Cash flow per share (Unadj.) Rs1.40.9 155.8%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs242.8137.7 176.3%  
Shares outstanding (eoy) m90.3061.25 147.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.82.0 40.4%   
Avg P/E ratio x-12.8-27.1 47.3%  
P/CF ratio (eoy) x239.6170.0 141.0%  
Price / Book Value ratio x1.41.1 124.6%  
Dividend payout %-5.90-   
Avg Mkt Cap Rs m29,6039,142 323.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,3201,265 578.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m36,8844,599 801.9%  
Other income Rs m1,352517 261.7%   
Total revenues Rs m38,2365,116 747.4%   
Gross profit Rs m83047 1,764.7%  
Depreciation Rs m2,433391 621.8%   
Interest Rs m2,61144 5,885.6%   
Profit before tax Rs m-2,862128 -2,235.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-553466 -118.8%   
Profit after tax Rs m-2,309-337 684.2%  
Gross profit margin %2.21.0 220.1%  
Effective tax rate %19.3363.5 5.3%   
Net profit margin %-6.3-7.3 85.3%  
BALANCE SHEET DATA
Current assets Rs m31,3535,623 557.6%   
Current liabilities Rs m29,9023,297 906.9%   
Net working cap to sales %3.950.6 7.8%  
Current ratio x1.01.7 61.5%  
Inventory Days Days7159 121.2%  
Debtors Days Days12948 269.6%  
Net fixed assets Rs m31,3007,028 445.3%   
Share capital Rs m90361 1,474.3%   
"Free" reserves Rs m21,0258,375 251.1%   
Net worth Rs m21,9288,436 259.9%   
Long term debt Rs m11,398202 5,652.6%   
Total assets Rs m63,73412,712 501.4%  
Interest coverage x-0.13.9 -2.5%   
Debt to equity ratio x0.50 2,174.6%  
Sales to assets ratio x0.60.4 159.9%   
Return on assets %0.5-2.3 -20.6%  
Return on equity %-10.5-4.0 263.2%  
Return on capital %-0.82.0 -37.7%  
Exports to sales %46.743.3 107.7%   
Imports to sales %024.4 0.0%   
Exports (fob) Rs m17,2131,992 864.0%   
Imports (cif) Rs mNA1,124 0.0%   
Fx inflow Rs m18,1131,992 909.2%   
Fx outflow Rs m6721,191 56.4%   
Net fx Rs m17,442801 2,176.5%   
CASH FLOW
From Operations Rs m444-4,225 -10.5%  
From Investments Rs m3,0254,303 70.3%  
From Financial Activity Rs m-2,139-184 1,164.3%  
Net Cashflow Rs m1,328-105 -1,264.7%  

Share Holding

Indian Promoters % 27.4 73.6 37.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 38.9 1.0 4,090.5%  
FIIs % 19.5 0.3 7,480.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 26.4 274.9%  
Shareholders   91,182 47,091 193.6%  
Pledged promoter(s) holding % 69.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES PHARMA SCIENCE With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on STRIDES PHARMA SCIENCE vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

STRIDES PHARMA SCIENCE vs Panacea Biotech Share Price Performance

Period STRIDES PHARMA SCIENCE Panacea Biotech S&P BSE HEALTHCARE
1-Day 1.16% -1.74% 1.18%
1-Month 0.35% -20.01% -0.75%
1-Year 176.88% 11.75% 61.82%
3-Year CAGR -3.35% -12.26% 18.16%
5-Year CAGR 10.98% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the STRIDES PHARMA SCIENCE share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of STRIDES PHARMA SCIENCE hold a 27.4% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of STRIDES PHARMA SCIENCE and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, STRIDES PHARMA SCIENCE paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of -5.9%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of STRIDES PHARMA SCIENCE, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.